Mary Furmato, CPM
Mary has over 30 years of experience with Fortrea (formerly Labcorp and Covance), including global project management experience and drug development experience in discovery, translational medicine and clinical development roles. Her clinical research experience includes range of neuroscience indications, such as schizophrenia (adult and pediatric), Alzheimer's disease, Parkinson's disease, anxiety, depression, bipolar disorder, sleep disorder, Tourette's and rare disorders. She has an extensive background in Phase I-III studies that require in-hospital patient settings and multiple department interactions. Mary also provides expert advice as she customizes sponsors' strategies to anticipate and mitigate risk, meet the needs of the target patient population and improve efficiencies and data quality.